Comparison of Cas9 activators in multiple species-Reference-Cited by-同舟云学术

Comparison of Cas9 activators in multiple species

Published:2016-05-23 Issue:7 Volume:13 Page:563-567
ISSN:1548-7091
Container-title:Nature Methods
language:en
Short-container-title:Nat Methods

Author:

Chavez Alejandro,Tuttle Marcelle,Pruitt Benjamin W^ORCID,Ewen-Campen Ben,Chari Raj,Ter-Ovanesyan Dmitry,Haque Sabina J,Cecchi Ryan J,Kowal Emma J K,Buchthal Joanna,Housden Benjamin E,Perrimon Norbert,Collins James J,Church George

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology,Biochemistry,Biotechnology

Link

http://www.nature.com/articles/nmeth.3871.pdf

Reference40 articles.

1. Sander, J.D. & Joung, J.K. CRISPR-Cas systems for editing, regulating and targeting genomes. Nat. Biotechnol. 32, 347–355 (2014).

2. Hsu, P.D., Lander, E.S. & Zhang, F. Development and applications of CRISPR-Cas9 for genome engineering. Cell 157, 1262–1278 (2014).

3. Garneau, J.E. et al. The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature 468, 67–71 (2010).

4. Jinek, M. et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337, 816–821 (2012).

5. Mali, P. et al. RNA-guided human genome engineering via Cas9. Science 339, 823–826 (2013).

Cited by 442 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in Nanoparticles as Non-Viral Vectors for Efficient Delivery of CRISPR/Cas9;Pharmaceutics;2024-09-11

2. Engineered Cas9 variants bypass Keap1-mediated degradation in human cells and enhance epigenome editing efficiency;Nucleic Acids Research;2024-09-04

3. Genetic therapies and potential therapeutic applications of CRISPR activators in the eye;Progress in Retinal and Eye Research;2024-09

4. The therapeutic implications of all-in-one AAV-delivered epigenome-editing platform in neurodegenerative disorders;Nature Communications;2024-08-23

5. Specific multivalent molecules boost CRISPR-mediated transcriptional activation;Nature Communications;2024-08-22